1. Home
  2. LEGN vs RHP Comparison

LEGN vs RHP Comparison

Compare LEGN & RHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • RHP
  • Stock Information
  • Founded
  • LEGN 2014
  • RHP 1991
  • Country
  • LEGN United States
  • RHP United States
  • Employees
  • LEGN N/A
  • RHP N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • RHP Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • RHP Real Estate
  • Exchange
  • LEGN Nasdaq
  • RHP Nasdaq
  • Market Cap
  • LEGN 7.0B
  • RHP 6.3B
  • IPO Year
  • LEGN 2020
  • RHP 1991
  • Fundamental
  • Price
  • LEGN $33.65
  • RHP $90.56
  • Analyst Decision
  • LEGN Strong Buy
  • RHP Buy
  • Analyst Count
  • LEGN 13
  • RHP 6
  • Target Price
  • LEGN $79.17
  • RHP $124.67
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • RHP 1.5M
  • Earning Date
  • LEGN 03-11-2025
  • RHP 04-30-2025
  • Dividend Yield
  • LEGN N/A
  • RHP 5.01%
  • EPS Growth
  • LEGN N/A
  • RHP N/A
  • EPS
  • LEGN N/A
  • RHP 4.38
  • Revenue
  • LEGN $627,241,000.00
  • RHP $2,339,501,000.00
  • Revenue This Year
  • LEGN $66.60
  • RHP $4.08
  • Revenue Next Year
  • LEGN $49.28
  • RHP $5.50
  • P/E Ratio
  • LEGN N/A
  • RHP $20.98
  • Revenue Growth
  • LEGN 119.97
  • RHP 8.75
  • 52 Week Low
  • LEGN $30.17
  • RHP $90.75
  • 52 Week High
  • LEGN $60.87
  • RHP $121.77
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 44.07
  • RHP 33.49
  • Support Level
  • LEGN $34.00
  • RHP $92.04
  • Resistance Level
  • LEGN $36.20
  • RHP $96.91
  • Average True Range (ATR)
  • LEGN 1.52
  • RHP 2.59
  • MACD
  • LEGN -0.25
  • RHP -0.29
  • Stochastic Oscillator
  • LEGN 25.18
  • RHP 15.41

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About RHP Ryman Hospitality Properties Inc. (REIT)

Ryman Hospitality Properties Inc is a lodging and hospitality real estate investment trust that specializes in upscale convention center resorts and country music entertainment experiences. Its core holdings are Gaylord Opryland Resort & Convention Center; Gaylord Palms Resort & Convention Center; Gaylord Texan Resort & Convention Center; Gaylord National Resort & Convention Center; and Gaylord Rockies Resort & Convention Center. The company has three business segments: Hospitality, which includes Gaylord Hotels properties, the Inn at Opryland, and the AC Hotel, Entertainment which includes the entertainment and media assets comprising OEG, and Corporate and Other, which includes corporate expenses. It derives the vast majority of its revenue from its Hospitality segment.

Share on Social Networks: